Partial Meniscectomy-induced Osteoarthritis is our model of the month. Osteoarthritis is the most common form of the arthritis, affecting millions of people worldwide.
Attend the next AFSSI's live free webinar and learn more about ANS Biotech. Save the date for 02JULY2020 at 03:00 PM (CEST) and register now. Happy to share a valuable time with you!
ANS Biotech announces the renewal of its Research Tax Credit (CIR) agreement for the 5 following years (2020-2024).
Last call for the next available ALGOGram Session. Don’t miss it! A decision-making guide in developing the all-important product profile for your test compounds
As part of its growing capabilities in the field of visceral pain, ANS Biotech is now equipped with a second electronic barostat distender to support you research projects in this pain area.
Despite the current situation related to the COVID-19 pandemic, all the ANS Biotech Team is ready and proud to launch the ALGOGramTM Summer session! Registration is now open.
Working from home or on site, all the pieces of the ANS Biotech puzzle stay strongly united and mobilized to pursue to proudly serve you.
We all need good news... Because good news is welcome, both in good times and bad, we are pleased to announce the launch of a new version of our model of Oxaliplatin-induced cold allodynia.
In the current global health context, ANS Biotech is mobilizing and adapting so as not to stop its support in the services for its Customers. We remain available online and fully mobilized for your projects.
We are pleased to announce that ANS Biotech is now an official registered vendor on the Science Exchange platform! Visit our Provider profile (https://www.scienceexchange.com/labs/ans-biotech) and easily start a collaboration with us!